29 October 2014 -- As the Ebola outbreak grows, a small but significant group of people is also growing - the Ebola survivors. The survivors have not found life easy on the other side of the Ebola ward. They have a range of symptoms - visual problems, body aches, such as joint, muscle and chest pain. It has become evident that physical after-effects of the disease are among the most pressing problems Ebola survivors face.
29 October 2014 -- A new WHO position paper examines the balance of benefits and harms in offering mammography screening to women after the age of 40 in a variety of settings. WHO is also issuing new guidelines for the referral of suspected breast cancer cases in low-resource settings, applicable to primary care.
28 October 2014 -- WHO welcomes the approval by Swissmedic, the Swiss regulatory authority for therapeutic products, for a trial with an experimental Ebola vaccine at the Lausanne University Hospital. This marks the latest step towards bringing safe and effective Ebola vaccines for testing and implementation as quickly as possible.
24 October 2014 -- WHO convened a high-level emergency meeting to look at the many complex policy issues that surround access to Ebola vaccines. Ways to ensure the fair distribution and financing of these vaccines were discussed, as well as plans for the different phases of clinical trials to be performed concurrently rather than consecutively, partnerships for expediting clinical trials, and proposals for getting all development partners moving in tandem and at the same accelerated pace.